Page 2 - Dose Adjustment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dose Adjustment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dose Adjustment Today - Breaking & Trending Today

Practical Considerations for Managing RR DTC With Systemic Therapy

Published: April 24, 2023

Comprehensive insight on best practices in dose adjustment and adverse event management in patients receiving systemic therapy for RR DTC.

Source: onclive.com

Related Topics:

Treatment ApproachesSequencing StrategiesDifferentiated Thyroid CancerSystemic TherapyThyroid CancerDtc CancerRr DtcRadioiodine RefractoryRadioiodine Refractory DtcFirst Line TherapyFirst Line TreatmentDose ReductionDose AdjustmentLenvatinib DosingMolecular TestingGermline TestingTitrating TherapyAdverse EventsDrug Adverse Event

Patient Scenario 1: RR DTC Managed With Frontline Lenvatinib

Published: April 24, 2023

Expert Marcia Brose, MD, PhD, reviews a patient case of radioiodine-refractory differentiated thyroid cancer (RR DTC) managed with frontline lenvatinib therapy.

Source: onclive.com

Related Topics:

Marcia BroseTreatment ApproachesSequencing StrategiesDifferentiated Thyroid CancerWith Frontline LenvatinibThyroid CancerDtc CancerRr DtcRadioiodine RefractoryRadioiodine Refractory DtcFirst Line TherapyFirst Line TreatmentDose ReductionDose AdjustmentLenvatinib DosingAdverse EventsDrug Adverse EventHypertension Management